Edward Kadel
12PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Mar 18, 2025
Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial.Jay Jasti, Hua Zhong, Vandana Panwar
|Mar 28, 2024
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer.Shilpa Gupta, Tu My To, Ryon Graf
|Jul 25, 2022
Clinico-Genomic Characterization of Patients with Metastatic Urothelial Carcinoma in Real-World Practice Identifies a Novel Bladder Immune Performance Index (BIPI).Bernadett Szabados, Mariano Ponz-Sarvisé, Robson Machado
|Apr 18, 2022
Molecular classification of hormone-sensitive and castration-resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens.Kobe C Yuen, Ben Tran, Angelyn Anton
|Jan 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial.Thomas Powles, Kobe C Yuen, Silke Gillessen
|Jun 26, 2021
Molecular determinants of response to PD-L1 blockade across tumor types.Romain Banchereau, Ning Leng, Oliver Zill
Pageof 2
Frequent Collaborators
3 joint publications
Romain Banchereau
3 joint publications
Mahrukh Huseni
3 joint publications
Sanjeev Mariathasan
3 joint publications
Thomas Powles
2 joint publications
Jane L Grogan
2 joint publications
David F McDermott
1 joint publications
Marie-Claire Wagle
1 joint publications
Daniel L Halligan
1 joint publications
Koen M Marien
1 joint publications
Yannick Waumans
